Sim&Cure
Shaping the future of endovascular treatments. For more information about our products, visit our website!
France
67 employees
Series A
Total: $3.00M
Health Care, Medical Devices
General Information
France
BounceWatch is an independent company data service, not affiliated with Sim&Cure. To contact Sim&Cure, visit sim-and-cure.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Sim&Cure compare?
A PDF of Sim&Cure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Sim&Cure soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
France Market
Health Care
About Sim&Cure
Business keywords: medical software, patient-specific, endovascular treatments, innovation, neurovascular, digital twin, AI technologies, simulation model, aneurysm treatment, vascular interventions, clinical collaborations, start-up funding, growth phase, US expansion
Services & Products
Target Customers
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | €3.00M | 2 |
|
23 May 2019 |
Sim&Cure Alternatives & Competitors
View All Alternatives
Precision Medicine Platform for Cardiovascular Interventions
Altegos™ - the first patient-specific, predictive decision support software for shock care
Transforming kidney disease care with one simple blood test.
FAQ About Sim&Cure
Source: BounceWatch company record for Sim&Cure, https://bouncewatch.com/company/simcure, updated 7 June 2025. When citing, please name BounceWatch and link this page.
